5,000 Yuan Consultation Fee Sparks Debate on China’s Healthcare Equity
A 5,000 yuan (approximately US$690) consultation fee charged by a top gynecologist at a prestigious Shanghai public hospital has ignited a fierce public debate in China, raising uncomfortable questions about healthcare pricing, the valuation of medical expertise, and whether public hospitals are drifting away from their fundamental mission of serving all citizens.
The Controversy
The fee is charged by Professor Liu Xishi, a nationally renowned gynecologist at the Obstetrics and Gynecology Hospital affiliated with Fudan University — China’s first specialized obstetrics and gynecology hospital and consistently ranked second nationally in its field. Known in medical circles as “Liu the Surgeon” (刘一刀), Professor Liu specializes in complex conditions including cervical cancer and uterine fibroids, and ranks in the top 0.17% globally in endometriosis research, according to The Paper.
The 5,000 yuan fee applies specifically to a Category D “special consultation” (特需门诊) at the hospital’s Qingpu campus, which opened in September 2023. However, the same doctor offers consultations at multiple price points across different campuses: a 50 yuan regular expert consultation at the Huangpu campus, a 480 yuan standard special consultation at Huangpu, and a 1,000 yuan Category C special consultation at Qingpu.
Conflicting Explanations Fuel Public Skepticism
Investigative reporting has revealed inconsistencies in official explanations about who the 5,000 yuan fee is actually for. Hospital department staff told Upstream News that the 5,000 yuan tier is not for initial consultations but is specifically for patients who have already been evaluated and confirmed to undergo surgery by Professor Liu. The Qingpu District Health Commission, however, stated that the fee belongs to the International Department’s special services, primarily targeting foreign nationals.
Adding to the confusion, testing of the hospital’s online booking system showed that the 5,000 yuan appointment rejects local medical insurance cards and only accepts out-of-province self-pay patients — a detail that aligns with neither explanation entirely. As Sina Health reported, the fee has been filed and approved with the Shanghai Municipal Health Commission, but the conflicting narratives have eroded public trust.
A Tale of Two Tiers
The most striking aspect of the controversy is the 100-fold price difference between Professor Liu’s cheapest and most expensive consultations. The 50 yuan slots at the Huangpu campus are fully booked through the end of June, while the 5,000 yuan slots at Qingpu remain available on multiple dates. As one patient with treatment experience noted, “For patients with serious illnesses seeking treatment from other provinces, considering the cross-province travel time and accommodation costs in Shanghai, thousand-yuan level consultation fees are actually within an acceptable range. For local patients, they can also try to book the daily outpatient and special consultation slots. Dr. Liu also has 50 yuan expert consultations and 480 yuan special consultations, but the former is very difficult to get.”
The Broader Debate: Public Good vs. Market Logic
The controversy has become a flashpoint for deeper anxieties about the direction of China’s healthcare reforms. The 5,000 yuan fee is entirely out-of-pocket — not covered by medical insurance — and even the 1,000 yuan tier offers minimal reimbursement, with Shanghai local medical insurance reimbursing only about 10-20 yuan on a 280 yuan consultation fee.
As NetEase noted in its analysis, critics argue that when top public hospital doctors allocate significant time to high-fee consultations, it reduces their availability for regular patients. The resource mismatch — expensive slots going unfilled while affordable ones are oversubscribed — has fueled accusations that public hospitals are creating a two-tier system that favors the wealthy.
Supporters of tiered pricing counter that Chinese doctors’ technical expertise has long been undervalued, and that market-based pricing can appropriately recognize top-tier medical talent. Multiple price tiers, they argue, allow patients with different means to access the same doctor.
What’s Next
In an editorial published on June 10, The Paper argued that the 5,000 yuan controversy should be viewed as a form of public feedback. “The number ‘5,000 yuan’ may have struck the public’s most sensitive nerve, but at its core, this is a collision between public sentiment and medical reality,” the editorial stated. It called for strengthening primary healthcare capacity, expanding the supply of quality medical resources, and advancing the tiered diagnosis and treatment system (分级诊疗) as fundamental solutions.
The debate leaves several key questions unanswered: What safeguards exist to ensure that regular, affordable consultations are not reduced by the expansion of special services? How can hospitals improve transparency in their pricing structures? And what role should government regulation play in balancing marketization with the fundamental principle of equitable access to healthcare?
As China’s healthcare system continues to evolve, the 5,000 yuan consultation fee may prove to be less an anomaly than a signpost — pointing to tensions that will only grow as the nation grapples with how to value medical expertise while preserving the public character of its hospitals.